litlas
Log inCreate account

Christopher M. Counter

Active 1992–2022

Also published as
Christopher M Counter
58
Papers
19,758
Citations
53
h-index
58
i10-index

Citations

Citations per year for Christopher M. Counter1992: 4 citations1993: 8 citations1994: 33 citations1995: 86 citations1996: 136 citations1997: 174 citations1998: 164 citations1999: 202 citations2000: 273 citations2001: 265 citations2002: 291 citations2003: 277 citations2004: 239 citations2005: 219 citations2006: 235 citations2007: 195 citations2008: 201 citations2009: 159 citations2010: 188 citations2011: 182 citations2012: 160 citations2013: 145 citations2014: 149 citations2015: 162 citations2016: 166 citations2017: 127 citations2018: 138 citations2019: 388 citations2020: 467 citations2021: 429 citations2022: 315 citations2023: 252 citations2024: 327 citations2025: 165 citations2026: 4 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,712 citing papers, 37.7% of this breakdownChina: 743 citing papers, 10.3% of this breakdownUnited Kingdom: 412 citing papers, 5.7% of this breakdownJapan: 330 citing papers, 4.6% of this breakdownGermany: 308 citing papers, 4.3% of this breakdownCanada: 265 citing papers, 3.7% of this breakdownItaly: 246 citing papers, 3.4% of this breakdownFrance: 225 citing papers, 3.1% of this breakdownAustralia: 197 citing papers, 2.8% of this breakdownSpain: 164 citing papers, 2.3% of this breakdownSouth Korea: 131 citing papers, 1.8% of this breakdownIndia: 116 citing papers, 1.6% of this breakdown
0%37.7%Other 18.7%

Institutions

Fields

  • Medicine48.6%
  • Biochemistry, Genetics and Molecular Biology40.7%
  • Immunology and Microbiology2.8%
  • Nursing2.7%
  • Materials Science1.6%
  • Neuroscience0.8%
  • Other2.8%

Topics

  • Telomeres, Telomerase, and Senescence9.3%
  • Mitochondrial Function and Pathology2.7%
  • DNA Repair Mechanisms2.2%
  • Cancer-related Molecular Pathways2.2%
  • RNA Interference and Gene Delivery2%
  • Advanced biosensing and bioanalysis techniques1.9%
  • Other79.7%

Coauthors

All papers

Open in search
  1. Erk2 Phosphorylation of Drp1 Promotes Mitochondrial Fission and MAPK-Driven Tumor Growth

    Authors: Jennifer A. Kashatus, Aldo Nascimento, Lindsey J. Myers, Annie Sher, Frances L. Byrne, Kyle L. Hoehn, Christopher M. Counter, David F. Kashatus - Molecular Cell 2015 cited by 705

  2. Copper is required for oncogenic BRAF signalling and tumorigenesis

    Authors: Donita C. Brady, Matthew S. Crowe, Michelle L. Turski, G. Aaron Hobbs, Xiaojie Yao, A. Chaikuad, Stefan Knapp, Kunhong Xiao, Sharon L. Campbell, Dennis J. Thiele, Christopher M. Counter - Nature 2014 cited by 612

  3. A model for RAS mutation patterns in cancers: finding the sweet spot

    Authors: Siqi Li, Allan Balmain, Christopher M. Counter - Nature reviews. Cancer 2018 cited by 392

  4. A Novel Role for Copper in Ras/Mitogen-Activated Protein Kinase Signaling

    Authors: Michelle L. Turski, Donita C. Brady, Hyung J. Kim, Byung-Eun Kim, Yasuhiro Nose, Christopher M. Counter, Dennis R. Winge, Dennis J. Thiele - Molecular and Cellular Biology 2012 cited by 317

  5. Copper Chelation Inhibits BRAFV600E-Driven Melanomagenesis and Counters Resistance to BRAFV600E and MEK1/2 Inhibitors

    Authors: Donita C. Brady, Matthew S. Crowe, Danielle Greenberg, Christopher M. Counter - Cancer Research 2017 cited by 166

  6. Creation of human tumour cells with defined genetic elements

    Authors: William C. Hahn, Christopher M. Counter, Ante S. Lundberg, Roderick L. Beijersbergen, Mary W. Brooks, Robert A. Weinberg - Nature 1999 cited by 2,352

  7. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells

    Authors: Elizabeth S. Yeh, Melissa Cunningham, Hugh Arnold, Dawn A. D. Chasse, Teresa Monteith, Gilles Ivaldi, William C. Hahn, P. Todd Stukenberg, Shirish Shenolikar, Takafumi Uchida, Christopher M. Counter, Joseph R. Nevins, Anthony R. Means, Rosalie C. Sears - Nature Cell Biology 2004 cited by 791

  8. RALA and RALBP1 regulate mitochondrial fission at mitosis

    Authors: David F. Kashatus, Kian‐Huat Lim, Donita C. Brady, Nicole L. Pershing, Adrienne D. Cox, Christopher M. Counter - Nature Cell Biology 2011 cited by 391

  9. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.

    Authors: Christopher M. Counter, Ariel A. Avilion, Catherine LeFeuvre, Nancy Stewart, Carol W. Greider, Calvin B. Harley, Silvia Bacchetti - The EMBO Journal 1992 cited by 2,109

  10. CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment

    Authors: Jennifer E. Klomp, Ye S. Lee, Craig M. Goodwin, Björn Papke, Jeffrey A. Klomp, Andrew M. Waters, Clint A. Stalnecker, Jonathan M. DeLiberty, Kristina Drizyte‐Miller, Runying Yang, J. Nathaniel Diehl, Hongwei Yin, Mariaelena Pierobon, Elisa Baldelli, Meagan B. Ryan, Siqi Li, Jackson J. Peterson, Amber R. Smith, James T. Neal, Aaron K. McCormick, Calvin J. Kuo, Christopher M. Counter, Emanuel F. Petricoin, Adrienne D. Cox, Kirsten L. Bryant, Channing J. Der - Cell Reports 2021 cited by 42

  11. Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis

    Authors: Brooke Ancrile, Kian‐Huat Lim, Christopher M. Counter - Genes & Development 2007 cited by 418

  12. hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization

    Authors: Matthew Meyerson, Christopher M. Counter, Elinor Ng Eaton, Leif W. Ellisen, Philipp Steiner, Stephanie Dickinson Caddle, Liuda Ziaugra, Roderick L. Beijersbergen, Michael J. Davidoff, Qingyun Liu, Silvia Bacchetti, Daniel A. Haber, Robert A. Weinberg - Cell 1997 cited by 1,801

  13. A Genetic Porcine Model of Cancer

    Authors: Lawrence B. Schook, Tiago Collares, Wenping Hu, Ying Liang, Fernanda Martins Rodrigues, Laurie A. Rund, Kyle M. Schachtschneider, Fabiana K. Seixas, Kuldeep Singh, Kevin D. Wells, Eric M. Walters, Randall S. Prather, Christopher M. Counter - PLoS ONE 2015 cited by 159

  14. Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability

    Authors: Hema Adhikari, Christopher M. Counter - Nature Communications 2018 cited by 92

  15. Tumour maintenance is mediated by eNOS

    Authors: Kian‐Huat Lim, Brooke B. Ancrile, David F. Kashatus, Christopher M. Counter - Nature 2008 cited by 321

  16. The telomere hypothesis of cellular aging

    Authors: Calvin B. Harley, Homayoun Vaziri, Christopher M. Counter, Richard Allsopp - Experimental Gerontology 1992 cited by 493

  17. Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression

    Authors: Songtao Shi, Stan Gronthos, Shaoqiong Chen, A. Hari Reddi, Christopher M. Counter, Pamela Gehron Robey, Cun-Yu Wang - Nature Biotechnology 2002 cited by 378

  18. Activation of RalA is critical for Ras-induced tumorigenesis of human cells

    Authors: Kian‐Huat Lim, Antonio T. Baines, James J. Fiordalisi, Michail Shipitsin, Larry A. Feig, Adrienne D. Cox, Channing J. Der, Christopher M. Counter - Cancer Cell 2005 cited by 361

  19. The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis

    Authors: Yi-Shan Lee, Kian‐Huat Lim, Xingrong Guo, Yoshiharu Kawaguchi, Ya‐sheng Gao, Tomasa Barrientos, Peter Ordentlich, Xiao‐Fan Wang, Christopher M. Counter, Tso‐Pang Yao - Cancer Research 2008 cited by 260

  20. A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution

    Authors: Grace R. Anderson, Peter Winter, Kevin Lin, Daniel P. Nussbaum, Merve Çakır, Elizabeth M. Stein, Ryan S. Soderquist, Lorin Crawford, Jim C. Leeds, Rachel Newcomb, Priya Stepp, Catherine Yip, Suzanne E. Wardell, Jennifer P. Tingley, Moiez Ali, Mengmeng Xu, Meagan B. Ryan, Shannon J. McCall, Autumn J. McRee, Christopher M. Counter, Channing J. Der, Kris C. Wood - Cell Reports 2017 cited by 86

  21. Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity

    Authors: Hema Adhikari, Walaa E. Kattan, S. Kumar, Pei Zhou, John F. Hancock, Christopher M. Counter - Nature Communications 2021 cited by 53

  22. Distinct responses to rare codons in select Drosophila tissues

    Authors: Scott R Allen, Rebeccah K Stewart, Michael Rogers, Ivan Jimenez Ruiz, Erez Cohen, Alain Laederach, Christopher M Counter, Jessica K Sawyer, Donald T Fox - eLife 2022 cited by 30

  23. Rare Codons Regulate KRas Oncogenesis

    Authors: Benjamin L. Lampson, Nicole L. Pershing, Joseph A. Prinz, Joshua R. Lacsina, William F. Marzluff, Christopher V. Nicchitta, David M. MacAlpine, Christopher M. Counter - Current Biology 2012 cited by 151

  24. Defining the Cooperative Genetic Changes That Temporally Drive Alveolar Rhabdomyosarcoma

    Authors: Sarasija Naini, Katherine T. Etheridge, Stacey J. Adam, Stephen J. Qualman, Rex C. Bentley, Christopher M. Counter, Corinne M. Linardic - Cancer Research 2008 cited by 84